New vaccine aims to shield HIV patients from hidden virus
NCT ID NCT05099965
First seen Oct 31, 2025 · Last updated May 09, 2026 · Updated 29 times
Summary
This study tested a vaccine called Triplex in 90 adults who have both HIV and cytomegalovirus (CMV). The goal was to see if the vaccine is safe and boosts the immune system's ability to fight CMV. Participants received either the vaccine or a placebo, and researchers monitored their immune responses and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alabama CRS
Birmingham, Alabama, 35222, United States
-
Case Clinical Research Site
Cleveland, Ohio, 44106, United States
-
Chapel Hill CRS
Chapel Hill, North Carolina, 27599, United States
-
Houston AIDS Research Team CRS
Houston, Texas, 77009, United States
-
Massachusetts General Hospital CRS (MGH CRS)
Boston, Massachusetts, 02114, United States
-
Penn Therapeutics, CRS
Philadelphia, Pennsylvania, 19104, United States
-
UCLA CARE Center CRS
Los Angeles, California, 90035-4709, United States
-
UCSD Antiviral Research Center
San Diego, California, 92103, United States
-
Ucsf Hiv/Aids Crs
San Francisco, California, 94110, United States
-
University of Colorado Hospital CRS
Aurora, Colorado, 80045, United States
-
University of Pittsburgh CRS
Pittsburgh, Pennsylvania, 15213, United States
-
Washington University Therapeutics (WT) CRS
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.